Lv6
1790 积分 2022-09-15 加入
Targeting CNS Metastases in Non–Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers
13天前
已完结
Long-Term Toxicity of Immune Checkpoint Inhibitors—Time to Widen the Lens
13天前
已完结
EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB‐1 proliferation index
13天前
已完结
Immune landscape and progress in immunotherapy for pituitary neuroendocrine tumors
17天前
已完结
Immune landscape and progress in immunotherapy for pituitary neuroendocrine tumors
19天前
已完结
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
26天前
已完结
Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study
27天前
已完结
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
30天前
已完结
Biomarkers for immunotherapy of hepatocellular carcinoma
30天前
已完结
LncRNA SNHG25 Promotes Glioma Progression Through Activating MAPK Signaling
1个月前
已完结
皖公网安备34019202002308
